ArticleDermatology and therapy2026
Clinical Efficacy of a 12% Pure Vitamin C Serum Across All Skin Phototypes: An Integrated In Vitro-In Vivo Evaluation.
Article in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSkin aging is associated with loss of collagen network qualitative and quantitative integrity, which are crucial for skin structure and function. Topical application of pure vitamin C (L-ascorbic acid) may alleviate signs of skin aging (e.g., wrinkles, lack of firmness). The objectives of this open-label, monocentric study were to determine whether topical treatment with a dermocosmetic serum containing a high concentration (12%) of pure vitamin C (PVC12 serum) could increase epidermal thickness and positively influence collagen fiber synthesis and organization, thus alleviating visible signs of skin aging.
methodsThis study investigated the efficacy and tolerability of PVC12 serum over 3 months compared with baseline. Healthy participants aged ≥18 years with any skin phototype received twice-daily treatment with the PVC12 serum. Evaluations included reflectance confocal microscopy measures and instrumental measures of skin firmness and elasticity, as well as clinical scoring of multiple skin aging signs.
resultsThe study included 49 women (skin phototypes I-VI). After 84 days of continuous use of PVC12 serum, epidermal thickness was significantly increased by 16.4% compared with baseline. More than half of the participants showed improvements in total collagen score and cross-linked collagen fibers. A significant decrease in coarse and curled collagen fibers was also observed. There was significant improvement in skin firmness and elasticity throughout the study. At the end of treatment, there were significant and clinically relevant improvements in various parameters (e.g., radiance, skin oiliness, pores). The treatment was well tolerated, with no occurrence of treatment-related adverse events.
conclusionPVC12 serum may exert beneficial effects on skin of all phototypes, including improved skin thickness, collagen fiber synthesis and quality, skin firmness and elasticity, and other parameters. This evidence supports the effectiveness and tolerability of pure vitamin C in the prevention and correction of skin aging signs over time.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.